These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 789791

  • 1. Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans.
    Kilbourne ED.
    J Infect Dis; 1976 Oct; 134(4):384-94. PubMed ID: 789791
    [Abstract] [Full Text] [Related]

  • 2. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR, Rizzone C, DeMello S, Ogra PL.
    Dev Biol Stand; 1976 Oct; 33():162-70. PubMed ID: 782964
    [Abstract] [Full Text] [Related]

  • 3. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
    Kilbourne ED, Cerini CP, Khan MW, Mitchell JW, Ogra PL.
    J Immunol; 1987 May 01; 138(9):3010-3. PubMed ID: 3571981
    [Abstract] [Full Text] [Related]

  • 4. Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition.
    Johansson BE, Pokorny BA, Tiso VA.
    Vaccine; 2002 Feb 22; 20(11-12):1670-4. PubMed ID: 11858877
    [Abstract] [Full Text] [Related]

  • 5. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine.
    Potter CW, Jennings R, Phair JP, Clarke A, Stuart-Harris CH.
    J Infect Dis; 1977 Mar 22; 135(3):423-31. PubMed ID: 850080
    [Abstract] [Full Text] [Related]

  • 6. Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans.
    Kilbourne ED, Couch RB, Kasel JA, Keitel WA, Cate TR, Quarles JH, Grajower B, Pokorny BA, Johansson BE.
    Vaccine; 1995 Dec 22; 13(18):1799-803. PubMed ID: 8701596
    [Abstract] [Full Text] [Related]

  • 7. [Antibody response to hemagglutinin and neuraminidase induced by an influenza subunit vaccine (author's transl)].
    Kuwert E, Werner J, Franke G, Paulus W.
    Zentralbl Bakteriol Orig A; 1979 Jun 22; 244(1):1-16. PubMed ID: 92113
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L, Kays SK, Zimmer G, von Messling V.
    J Virol; 2018 Sep 01; 92(17):. PubMed ID: 29925654
    [Abstract] [Full Text] [Related]

  • 11. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. III. Reduced generation of neuraminidase-specific helper T cells in hemagglutinin-primed mice.
    Johansson BE, Moran TM, Bona CA, Kilbourne ED.
    J Immunol; 1987 Sep 15; 139(6):2015-9. PubMed ID: 2957444
    [Abstract] [Full Text] [Related]

  • 12. Antibody response to influenza vaccination in healthy adults.
    Brydak LB, Tadeusz S, Magdalena M.
    Viral Immunol; 2004 Sep 15; 17(4):609-15. PubMed ID: 15671759
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cell-mediated immune responses to the hemagglutinin and neuraminidase antigens of influenza A virus after immunization in humans.
    Chow TC, Beutner KR, Ogra PL.
    Infect Immun; 1979 Jul 15; 25(1):103-9. PubMed ID: 478632
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents.
    Ben-Yehuda A, Joseph A, Barenholz Y, Zeira E, Even-Chen S, Louria-Hayon I, Babai I, Zakay-Rones Z, Greenbaum E, Galprin I, Glück R, Zurbriggen R, Kedar E.
    Vaccine; 2003 Jul 04; 21(23):3169-78. PubMed ID: 12804845
    [Abstract] [Full Text] [Related]

  • 16. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
    Monto AS, Petrie JG, Cross RT, Johnson E, Liu M, Zhong W, Levine M, Katz JM, Ohmit SE.
    J Infect Dis; 2015 Oct 15; 212(8):1191-9. PubMed ID: 25858957
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A single-radial haemolysis technique for measurement of antibody to influenza virus neuraminidase in equine sera.
    Gibson CA, Wood JM, Mumford J, Schild GC, Bevan AM.
    J Virol Methods; 1985 Aug 15; 11(4):299-308. PubMed ID: 4055974
    [Abstract] [Full Text] [Related]

  • 20. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC, Johansson BE.
    Virology; 2005 Sep 01; 339(2):273-80. PubMed ID: 15996702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.